On Air Now

Listen

Listen Live Now » 98.5 FM Battle Creek, Michigan

Weather

Current Conditions(Battle Creek,MI 49017)

More Weather »
79° Feels Like: 81°
Wind: W 12 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 79°

Tonight

Thunderstorms Late 64°

Tomorrow

Thunderstorms 83°

Alerts

GlaxoSmithKline lung drug Anoro approved in Europe

LONDON (Reuters) - GlaxoSmithKline said on Thursday its new inhaled lung drug, Anoro, had been approved in Europe as a treatment for chronic lung disease, boosting its respiratory franchise.

A final green light had been expected for the product, which was developed with Theravance, following a recommendation from European experts in February.

Respiratory drugs are a major business for GSK. Advair or Seretide, its market-leading lung drug, makes up a fifth of its sales, but it is already facing competition from generic versions in Europe.

Industry analysts expect Anoro to generate worldwide annual sales of about $2.65 billion by 2019, according to Thomson Reuters data.

(Reporting by Ben Hirschler; editing by Jane Baird)

Comments